Can daily CBD reshape your stress response? a study puts it to the test.

NCT ID NCT07069478

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This study investigates whether people who use cannabidiol (CBD) regularly react differently to acute stress compared to those who do not. Healthy adults aged 21–70 who either use CBD daily or not at all will undergo a series of stressful tasks — including public speaking, mental arithmetic, and an ice-water hand immersion — while researchers measure changes in mood, heart activity, and stress hormone levels. The goal is to understand the psychobiological mechanisms behind CBD's potential stress-relieving effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
cannabidiol (CBD)
What this could lead to
If regular CBD use dampens the stress response, it could point toward a natural approach for managing everyday stress and anxiety.
What could go wrong
This is an observational comparison, not a controlled trial, so it cannot prove cause and effect. Differences between CBD users and non-users (like tobacco use) may influence results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE STRESS REACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute stress disorder red-green color blindness Stress Disorders, Traumatic, Acute

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Minnesota

    RECRUITING

    Minneapolis, Minnesota, 55455, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.